Francesco Tannura: The Potential of the Khorana Risk Score for PE Stratification in Lung Cancer
Francesco Tannura, Clinical Fellow at Ramón y Cajal University Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers MDPI, adding:
”I am pleased to announce that our work, titled ‘Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic Markers’, has just been published in Cancers (Cancers MDPI).
This research evaluates the performance of current risk stratification models for pulmonary embolism in lung cancer patients, and explores the potential of the Khorana Risk Score.
I am grateful to my supervisors, for their support and guidance throughout this journey (Roberta Pancani, Alessandro Celi, Laura Carrozzi).
This publication marks an important milestone for me, providing a solid foundation for my current research field.”
Title: Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic Markers
Authors: Francesco Tannura, Andrea Sbrana, Antonio Chella, Francesco Pistelli, Laura Carrozzi, Alessandro Celi, Roberta Pancani
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia